Surgical Treatment for Infective Endocarditis: A Single-Centre Experience
25 September 2015
12 February 2016
13 April 2016 (online)
Background A considerable proportion of patients with acute infective endocarditis require surgical treatment. The aim of this study was to collate our short- and medium-term results of surgical treatment of infective endocarditis and to compare the results in native and prosthetic endocarditis.
Method Total 254 operations for infective endocarditis from January 2008 to May 2015 were included in this retrospective study. There were 182 operations for native valve endocarditis and 72 for prosthetic valve endocarditis. Patient characteristics, operative details, complications, and mortality were registered.
Results The endocarditis was left sided in 247 operations (146 aortic, 78 mitral, and 23 double-valve) and right-sided in 7 (5 tricuspid and 2 pulmonary). Twenty-two patients (8.7%) died within 30 days (7.7% with native valve endocarditis and 11.1% with prosthetic valve endocarditis, p = 0.31). Severe perioperative complications occurred in 99 of 254 operations (39%). Overall cumulative survival at 1 and 5 years was 86% and 75%, respectively, and it was not significantly different for native and prosthetic endocarditis (p = 0.31). Eighteen patients (8%) had one (n = 16) or two (n = 2) recurrent episodes of endocarditis requiring surgery.
Conclusion Surgery for infective endocarditis is still associated with a high early mortality rate and a considerable complication rate. Long-term outcome is acceptable. In our study population, morbidity and mortality were not significantly different in native and prosthetic endocarditis.
- 1 Thuny F, Beurtheret S, Mancini J , et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 2011; 32 (16) 2027-2033
- 2 Wang A, Pappas P, Anstrom KJ , et al; International Collaboration on Endocarditis Investigators. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J 2005; 150 (5) 1086-1091
- 3 Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363 (9403): 139-149
- 4 Habib G, Lancellotti P, Antunes MJ , et al; 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for CardioThoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36 (44) 3075-3128
- 5 David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg 2007; 133 (1) 144-149
- 6 Rekik S, Trabelsi I, Maaloul I , et al. Short- and long-term outcomes of surgery for active infective endocarditis: a Tunisian experience. Interact Cardiovasc Thorac Surg 2009; 9 (2) 241-245
- 7 Musci M, Hübler M, Amiri A , et al. Surgical treatment for active infective prosthetic valve endocarditis: 22-year single-centre experience. Eur J Cardiothorac Surg 2010; 38 (5) 528-538
- 8 Ruttmann E, Legit C, Poelzl G , et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg 2005; 130 (3) 765-771
- 9 d'Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z. Long-term results of operation for paravalvular abscess. Ann Thorac Surg 1996; 62 (1) 48-53
- 10 Aksoy O, Meyer LT, Cabell CH, Kourany WM, Pappas PA, Sexton DJ. Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patients. Scand J Infect Dis 2007; 39 (2) 101-107
- 11 Jernberg T, Attebring MF, Hambraeus K , et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 2010; 96 (20) 1617-1621
- 12 Piper C, Körfer R, Horstkotte D. Prosthetic valve endocarditis. Heart 2001; 85 (5) 590-593
- 13 Akins CW, Miller DC, Turina MI , et al; Councils of the American Association for Thoracic Surgery; Society of Thoracic Surgeons; European Association for Cardio-Thoracic Surgery; Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 2008; 135 (4) 732-738
- 14 Perrotta S, Aljassim O, Jeppsson A, Bech-Hanssen O, Svensson G. Survival and quality of life after aortic root replacement with homografts in acute endocarditis. Ann Thorac Surg 2010; 90 (6) 1862-1867
- 15 David TE, Feindel CM, Armstrong S, Sun Z. Reconstruction of the mitral anulus. A ten-year experience. J Thorac Cardiovasc Surg 1995; 110 (5) 1323-1332
- 16 Aranki SF, Adams DH, Rizzo RJ , et al. Determinants of early mortality and late survival in mitral valve endocarditis. Circulation 1995; 92 (9, Suppl): II143-II149
- 17 Sabik JF, Lytle BW, Blackstone EH, Marullo AG, Pettersson GB, Cosgrove DM. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 2002; 74 (3) 650-659 , discussion 659
- 18 Musci M, Weng Y, Hübler M , et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year single-center experience. J Thorac Cardiovasc Surg 2010; 139 (3) 665-673
- 19 Yankah AC, Pasic M, Klose H, Siniawski H, Weng Y, Hetzer R. Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. Eur J Cardiothorac Surg 2005; 28 (1) 69-75